Find a Research Expert

Experts
 Menu

E W McDermott

Institution

University College Dublin

Contact

Subjects

Medicine & Nursing

Biochemistry

Details
Publications 49
As first author 3
As last author 3
Unique topics 353
Collaborations 60
Sources 9
Are you E W McDermott? Click here to provide feedback on your profile.
All
2018
2017
2016
2015
2012
2011
2010
2009
2008
Earlier
All
2018
2017
2016
2015
2012
2011
2010
2009
2008
Earlier

2018

Impact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the "one thousand HER2 patients" project.
2018

Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trial.
2017

Atypia of Undetermined Significance in Thyroid Fine Needle Aspirates: a 4-Year Audit of Thy3a Reporting.
2017

Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma.
2016

Use of Multiparameter Tests for Identifying Women with Early Breast Cancer Who Do Not Need Adjuvant Chemotherapy.
2016

Validated biomarkers: The key to precision treatment in patients with breast cancer.
2015

Biomarkers in Breast Cancer: Where Are We and Where Are We Going?
2015

High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients.
2015

The Value of Isosulfan Blue Dye in Addition to Isotope Scanning in the Identification of the Sentinel Lymph Node in Breast Cancer Patients With a Positive Lymphoscintigraphy: A Randomized Controlled Trial (ISRCTN98849733).
2012

Tumor profiling using protein biomarker panels in malignant melanoma: application of tissue microarrays and beyond.
2011

Focal thyroid incidentalomas identified with whole-body FDG-PET warrant further investigation.
2011

Functional and prognostic relevance of the homeobox protein MSX2 in malignant melanoma.
2011

Src: a potential target for the treatment of triple-negative breast cancer.
2010

Levels of specific glycans significantly distinguish lymph node-positive from lymph node-negative breast cancer patients.
2010

mTOR in breast cancer: differential expression in triple-negative and non-triple-negative tumors.
2009

The role of oestrogen receptor {alpha} in human thyroid cancer: contributions from coregulatory proteins and the tyrosine kinase receptor HER2.
2008

ADAM-17 predicts adverse outcome in patients with breast cancer.
2008

Cyclooxygenase-2 predicts adverse effects of tamoxifen: a possible mechanism of role for nuclear HER2 in breast cancer patients.
2006

CA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancer.
2005

Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer.
2005

Meralgia paraesthetica following open appendicectomy.
2004

Expression and prognostic relevance of Mcl-1 in breast cancer.
2004

Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer.
2004

Expression of the breast cancer metastasis suppressor gene, BRMS1, in human breast carcinoma: lack of correlation with metastasis to axillary lymph nodes.
2004

Overexpression of the Ets-1 transcription factor in human breast cancer.
2004

Positron emission tomography in the staging and management of breast cancer.
2003

Caspase 3 in breast cancer.
2003

Elevated expression and altered processing of fibulin-1 protein in human breast cancer.
2003

Expression of ADAM-9 mRNA and protein in human breast cancer.
2003

Factors affecting metastases to non-sentinel lymph nodes in breast cancer.
2003

Intradermal radioisotope injection optimises sentinel lymph node identification in breast cancer.
2003

Successful conservative management of neutropenic enterocolitis: a report of two cases and review of the literature.
2003

The role of molecular staging in malignant melanoma.
2003

Unusual presentation of a giant parathyroid adenoma: report of a case.
2002

Anti-human epidermal growth factor receptor 2 monoclonal antibody therapy for breast cancer.
2001

Adult intussusception: a report of five cases.
2001

Post-partum ovarian vein thrombosis.
2000

Tissue iodine content and serum-mediated 125I uptake-blocking activity in breast cancer.
1998

Ret-proto-oncogene analysis in medullary thyroid carcinoma.
1998

Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma.
1997

Ductal carcinoma in situ of the breast--current management.
1997

Hereditary breast cancer.
1997

Irish guidelines for surgeons in the management of breast cancer. Irish Society of Surgical Oncology.
1996

Thyroid disorders and breast cancer.
1994

Audit of complete axillary dissection in early breast cancer.
1993

Laparoscopic truncal vagotomy without drainage.
1992

Dietary alcohol intake does not increase the incidence of experimentally induced mammary carcinoma.
1990

CEA and CA 15-3 in primary and recurrent breast cancer.
1989

Effect of mechanical bowel preparation on anastomotic integrity following low anterior resection in dogs.

These arethe9 unique sources for E W McDermott's 49 publications. A single publication may appear in multiple sources. Click on a name or publication count to see the publications for a particular source.

Source #
Ireland -> Dublin City University 5
Ireland -> Dublin City University -> PubMed 5
Ireland -> National University of Ireland Galway 1
Ireland -> National University of Ireland Galway -> PubMed 1
Ireland -> Royal College of Surgeons in Ireland 3
Ireland -> Royal College of Surgeons in Ireland -> PubMed 1
Ireland -> Trinity College Dublin 1
Ireland -> University College Dublin 40
Ireland -> University College Dublin -> PubMed 40

  1. Further insights

    Clicking through these tabs will give you a wealth of further insights into this expert through their commonly used topics, the evolution of their expertise, their collaborators and their publications.

  2. Details

    Here is a quick breakdown of this expert's publication history

  3. Contact

    If this is the expert you have been looking for, simply click here to make contact.